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S U M M A R Y
Scedosporium apiospermum is a ﬁlamentous fungus present in soil and polluted waters that may cause
infection by direct inoculation. Osteomyelitis represents a challenge both for diagnosis and treatment.
We report a case of post-tsunami primary S. apiospermum osteomyelitis of the knee in an
immunocompetent patient.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Scedosporium apiospermum is a ﬁlamentous fungus present in
soil and polluted waters that may cause infections in humans.1,2 In
immunocompetent hosts, these hyaline molds produce localized
disease, such as chronic local soft tissue suppurative fungal
infections known as maduromycosis (or eumycotic mycetoma, or
‘Madura foot’ after the clinical description of patients with pedal
mycetoma near Madura, India), or more rarely septic arthritis/
osteomyelitis after a penetrating trauma.3 Near-drowning inci-
dents and recent natural disasters, such as the Indonesian tsunami
in 2004, have shown S. apiospermum and Scedosporium aurantia-
cum to be the causes of fatal central nervous system infections and
pneumonia in immunocompetent victims who have aspirated
polluted water,4 as well as systemic infections in immunocom-
promised patients.5 To our knowledge, this is the ﬁrst reported
case of post-tsunami primary S. apiospermum osteomyelitis of the
knee in an immunocompetent patient.
2. Case report
A 27-year-old woman was referred to our institution due to an
osteomyelitis caused by S. apiospermum. She is a survivor of the* Corresponding author. Tel.: +39 051 6366222; fax: +39 051 6366540.
E-mail address: andrea.angelini83@libero.it (A. Angelini).
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http://dx.doi.org/10.1016/j.ijid.2013.02.011Indonesian tsunami of 2004. During that experience she reported a
traumatic rupture of the patellar tendon, the extensor hallucis
longus tendon, and the anterior tibial tendon of the left leg. A
surgical suture of all three tendons and plastic revision of the skin
was performed a month later. During the following 2 years she
reported chronic mild pain in the left knee. X-rays of the knee
showed no abnormalities. Magnetic resonance imaging (MRI)
revealed signal alteration in the medial femoral condyle that
seemed to be related to a post-traumatic trabecular contusion
(Figure 1, a and b). The patient was followed and treated with
rehabilitation.
A new MRI performed 1 year later due to persistence of symptoms
showed a liquid cyst adjacent to the patellar tendon (Figure 1, c and
d). A surgical excision was performed, and histological analysis
showed a chronic inﬂammatory process; no microorganism was
isolated from cultures. Thereafter she was followed annually, with
MRI of the left knee showing a progressive signal alteration of bone
with ovoid osteolytic areas (Figure 1, e and f).
An open surgical biopsy (2.5 years from the previous surgery)
was performed and histological analysis was consistent with
chronic osteomyelitis. After curettage and placement of a
bioabsorbable hydroxyapatite implant (PerOssal, certiﬁed class
III medical device; aap Implantate AG, Berlin, Germany) loaded
with vancomycin, the patient was treated with teicoplanin 400 mg
once a day for 6 weeks, taking into consideration that the most
frequent bone osteomyelitis post-tsunami was caused by Gram-
negative bacteria.1 Cultures of the surgical material revealed noses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Initial MRI 4 months after the tsunami. Coronal T2-weighted fat-suppressed image showing a medial femoral condyle abnormality (white arrow) (a). Sagittal MRI
showing aspeciﬁc abnormalities in the anterior part of the knee (b). MRI performed 1 year later showing a liquid cyst adhering to the surface of the patellar tendon (asterisk) (c
and d). Sagittal MRI of the left knee performed 4 years (e) and 4.5 years (f) after the trauma showing a progressive signal alteration of the tibial cancellous bone in the meta-
epiphyseal region (black asterisk) associated with an abnormal cystic lesion (grains) in the soft tissue (white arrow).
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identiﬁed as a Scedosporium species. Based on morphological
(Figure 2) and molecular (the BT2 fragment of the beta-tubulin
gene was used for clade identiﬁcation, as previously reported byGilgado et al.2) studies, the fungus was typed as S. apiospermum
(clade 4).2
In vitro susceptibility testing of the strain was performed
following the Clinical and Laboratory Standards Institute (CLSI;
Figure 2. Microscopic views of Scedosporium apiospermum showing septate hyphae, conidiophores, and ovoid conidia. Magniﬁcation, 100. Conidia (annelloconidia) are
unicellular, pale brown, ovoid with truncate bases formed singly or in small clusters at the ends of the conidiophores, or from short annellidic necks arising directly from the
hyphae (arrowhead). Hyphae are hyaline and septate (black arrow).
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concentrations, deﬁned as the lowest concentrations that pro-
duced complete inhibition of growth (MICs-0), were: amphotericin
B, 8 mg/l; itraconazole, 16 mg/l; ﬂuconazole, 32 mg/l; 5-ﬂuorocy-
tosine, 64 mg/l; voriconazole, 0.5 mg/l; posaconazole, 0.5 mg/l. A
new surgical treatment was performed with curettage, removal of
the bone substitute, and cavity ﬁlling with bone cement.
Antifungal therapy was started with voriconazole 400 mg three
times daily on day 1, then 200 mg four times daily for 6 months,
with monitoring of serum voriconazole levels. During the latter
treatment the patient’s general condition showed some improve-
ment. No side effects were apparent at this dosage.
During follow-up after fungal therapy was complete, the
patient showed no signs or symptoms of infection. However
during the next 6 months a gradual clinical deterioration was
registered with progressive changes on MRI. A new ﬁne-needle
aspiration was performed and S. apiospermum was isolated on
cultures. The MICs-0 were: amphotericin B, 4 mg/l; itraconazole,
16 mg/l; ﬂuconazole, 32 mg/l; 5-ﬂuorocytosine, >64 mg/l; vor-
iconazole, 0.25 mg/l; posaconazole, 0.5 mg/l. Since antifungal
therapy had been unsuccessful (the patient was in pain, with
clear signs of inﬂammation of the knee and skin ﬁstula, and MRI
showed an additional osteolytic lesion), a new accurate surgical
debridement was performed and the antifungal treatment was
changed to posaconazole 200 mg four times daily with food,
associated with terbinaﬁne 250 mg once a day. This aggressive
therapy was suggested by our specialist infectious disease
consultant in agreement with an analysis of the literature.3,7,8Terbinaﬁne was commenced empirically even though a MIC value
was not available. Serum posaconazole levels were monitored
during therapy. The pain and local signs of inﬂammation
diminished gradually and the wound healed by primary intention.
After 1 year the patient was still receiving antifungal therapy
without signs of relapse. A renewed MRI showed no signs of
progression of infection.
3. Discussion
The genus Scedosporium consists of different species that can
affect practically all the organs of the body.2 These species are
ubiquitous ascomycetous ﬁlamentous fungi that have been recov-
ered from soil, manure, sewage, and polluted waters.2,3 It is
recognized that Scedosporium species cause subcutaneous infec-
tions, osteomyelitis, and arthritis after accidental penetrating
traumas, invasive surgical procedures, and near-drowning epi-
sodes.3 Its signiﬁcance as a potential pathogen of disaster evacuees
has led to its recent inclusion in the Centers for Disease Control and
Prevention list of infectious etiologies in persons with altered mental
status, central nervous system syndromes, or respiratory illness.
To the best of our knowledge, there are 35 cases of bone
infection caused by Scedosporium species or Pseudallescheria boydii
in immunocompetent patients reported in the literature (Supple-
mentary Material Table 1) and none of them were reported in
tsunami survivors. The case history presented here is a post-
tsunami localized knee infection caused by ﬁlamentous fungi of
the genus Scedosporium in an immunocompetent patient.
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slowly and indolently, but after months or years multiple nodules
can appear and spontaneously drain purulent material.3 Once
implanted, these organisms adapt to the host tissue environment
and grow within grains, showing as granulomatous ‘tumors’ at
histopathological examination. Identiﬁcation of S. apiospermum is
based chieﬂy on the morphologic characteristics of the asexual
structures produced by the mold in culture and by physiological
and molecular (beta-tubulin gene) study.2,3
The early diagnosis of infection by S. apiospermum and
differentiation from other agents of hyalohyphomycosis is
imperative because of its resistance to commonly given antifungal
agents, such as amphotericin B, ﬂucytosine, ketoconazole, micon-
azole, ﬂuconazole, itraconazole, and caspofungin.8 However,
voriconazole has shown some in vitro activity,8 and numerous
reports have detailed its clinical effectiveness against Scedospor-
ium infections, including those involving the central nervous
system and bone.9 On the basis of current opinion, voriconazole
(6 mg/kg twice daily on day 1 then 4 mg/kg twice daily) is the
treatment of choice for S. apiospermum (clade 4) infections,3,9 while
posaconazole is an alternative to voriconazole in salvage therapy.8
A combination therapy of terbinaﬁne and voriconazole has been
reported to be synergistic in vitro against Scedosporium species.3,7,8
This synergistic interaction has been explained based on the
mechanisms of action of azoles and terbinaﬁne, which block
different steps of the same pathway of fungal ergosterol
biosynthesis.3 Due to the rare nature of this infection, there are
no prospective randomized studies that have compared antifungal
agents or established the duration of therapy. However the need
for a multidisciplinary approach to managing this complicated
infection and the role of extensive surgical debridement combined
with protracted antifungal therapy for cure is generally empha-
sized.3 In some cases the outcome can result in radical excision or
amputation (Supplementary Material Table 1). In our case,
although S. apiospermum isolated on cultures was sensitive to
voriconazole in vitro, the patient needed more than one surgical
debridement and combined antifungal therapy (posaconazole and
terbinaﬁne) because the prolonged voriconazole treatment was
ineffective. Of note, the patient responded until the voriconazole
treatment was stopped, and this too-early discontinuation could
have been the cause of the failure/relapse.
In conclusion, although a rare organism, S. apiospermum
represents one of the possible emerging pathogens that
physicians should be aware of when treating immunocompetent
patients. An early and correct diagnosis of infection should be
made after a penetrating trauma and a subsequent long history
of symptoms in order to avoid more extensive surgery or possible
dissemination or death. We recommend the inclusion of an
infectious disease specialist and an experienced pathologist on
the medical team, to provide useful input both for diagnosis and
treatment. Due to the rarity of the disease, an extensive review of
the literature is necessary. Although it is not possible to provide
recommendations from a single report, our case has shown thatcombined surgical debridement and adequate aggressive anti-
fungal therapy over a long period of time may be the treatment of
choice in S. apiospermum osteomyelitis, and can result in a good
clinical outcome. The optimal antifungal regimen for this
infection is currently under investigation. However prolonged
treatment and careful long-term follow-up are essential to
eradicate the infection.
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